Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update

Go back to Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update
(NASDAQ: PRLD) Delayed: 4.59 -0.08 (1.71%)
Previous Close $4.67    52 Week High
Open $4.72    52 Week Low
Day High $4.75    P/E N/A 
Day Low $4.56    EPS
Volume 519,447